SYKStryker Corporation
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $3.52Missed
- vs $3.56 expected on Oct 29
- Stock move on it
- −6.38%
- one session
- Typical move
- ±6.4%
- average over 2 reports
- Price
- $312.38
- −2.01% today · $135B cap
Past and upcoming reports
2
| Oct 29, 2026 | Sep 30, 2026 | Time not given | $3.56 | Missed$3.52 | −6.38% |
| Jul 30, 2026 | Jun 30, 2026 | Time not given | $3.47 | Missed$3.13 | −6.42% |
After the report
Jul 30, 2026 report
This covers the Jul 30, 2026 report. The Oct 29, 2026 numbers are in the table above.
Stryker Q2 Miss: EPS Misses by 9.5%, Stock Tanks 6.4%
Stryker reported Q2 2026 EPS of $3.13, missing the $3.46 consensus by 9.5% (-$0.33). The stock fell 6.4% on the day to $325.61, wiping out recent momentum. Despite a buy-tilted consensus (20 buy, 4 hold, 0 sell) and a 17% upside to analyst target, the magnitude of the miss suggests operational or mix headwinds.
Reported against expected
MissedMissed consensus EPS by 9.5% ($3.13 actual vs $3.46 estimated, -$0.33 surprise).
Guidance
Not reported in payload. no explicit forward guidance available.
How the stock reacted
Stock fell 6.4% on the trading day after the print, from previous close of $348.04 to $325.61, with elevated volume of 3.97M shares.
What changed
EPS miss of 9.5% vs consensus, triggering a 6.4% single-day selloff.
What the price now assumes
Pricing in the miss as a sign of margin or operational pressure. volume spike confirms aggressive repositioning.
What it means for the business
Downgrade bias near-term. watch next quarter’s margin cadence and any updated guidance for recovery signs.
The next one to three months, as we saw it then
Better case25%
The miss is transitory (e.g., one-time charge or timing), and underlying growth resumes. Analyst target of $389 still implies 17% upside.
Base case50%
Stock consolidates in the $315-$335 range as the market digests the miss and awaits Q3 evidence of stabilization.
Worse case25%
The miss signals structural margin degradation or demand weakness, prompting multiple compression from current 33.8x P/E.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.